Could a missing milk compound save tiny Babies' guts and brains?
NCT ID NCT06547424
Summary
This early-stage study aimed to test the safety of a supplement called chondroitin sulfate for treating a severe intestinal disease (NEC) in premature, low-birth-weight babies. Researchers wanted to see if this compound, which is found in human breast milk but not most formulas, could help control the disease, reduce the need for surgery, and improve long-term brain development. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTESTINAL ISCHEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.